Search: onr:"swepub:oai:research.chalmers.se:bd82053d-92e6-41ec-a90d-b059afb89545" >
One-carbon metaboli...
One-carbon metabolism markers are associated with cardiometabolic risk factors
-
- Vendelbo Lind, Mads, 1988 (author)
- Chalmers tekniska högskola,Chalmers University of Technology,Köpenhamns universitet,University of Copenhagen
-
- Lauritzen, L. (author)
- Köpenhamns universitet,University of Copenhagen
-
- Vestergaard, H. (author)
- Steno Diabetes Center,Köpenhamns universitet,University of Copenhagen
-
show more...
-
- Hansen, T. (author)
- Köpenhamns universitet,University of Copenhagen
-
- Pedersen, O. B. (author)
- Köpenhamns universitet,University of Copenhagen
-
- Kristensen, M. (author)
- Köpenhamns universitet,University of Copenhagen
-
- Ross, Alastair, 1976 (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
show less...
-
(creator_code:org_t)
- Elsevier BV, 2018
- 2018
- English.
-
In: Nutrition, Metabolism and Cardiovascular Diseases. - : Elsevier BV. - 0939-4753 .- 1590-3729. ; 28:4, s. 402-410
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://research.cha...
-
show less...
Abstract
Subject headings
Close
- Background and aims: Alterations to one-carbon metabolism, especially elevated plasma homocysteine (Hcy), have been suggested to be both a cause and a consequence of the metabolic syndrome (MS). A deeper understanding of the role of other one-carbon metabolites in MS, including s-adenosylmethionine (SAM), s-adenosylhomocysteine (SAH), and the methylation capacity index (SAM:SAH ratio) is required. Methods and results: 118 men and women with MS-risk factors were included in this cross-sectional study and cardiometabolic outcomes along with markers of one-carbon metabolism, including fasting plasma SAM, SAH, Hcy and vitamin B12concentrations, were analysed. Multiple linear regression models were also used to examine the association between plasma one-carbon metabolites and cardiometabolic health features. We found that fasting plasma concentrations of Hcy, SAM and SAH were all positively correlated with markers of adiposity, including BMI (increase in BMI per 1-SD increase in one-carbon metabolite: 0.92 kg/m295% CI (0.28; 1.56), p = 0.005; 0.81 (0.15; 1.47), p = 0.02; 0.67 (−0.01; 1.36), p = 0.05, respectively). Hcy, but not SAM, SAH or SAM:SAH ratio was associated with BMI and body fat percentage after mutual adjustments. SAM concentrations were associated with higher fasting insulin (9.5% 95% CI (0.3; 19.5) per SD increase in SAM, p = 0.04), HOMA-IR (10.8% (0.8; 21.9), p = 0.03) and TNF-α (11.8% (5.0; 19.0), p < 0.001). Conclusion: We found little evidence for associations between SAM:SAH ratio and cardiometabolic variables, but higher plasma concentrations of SAM, SAH and Hcy are related to an overall higher risk of metabolic dysfunctions. The studies were registered at www.clinicaltrials.gov (NCT01719913 & NCT01731366).
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Annan klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Other Clinical Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Näringslära (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Nutrition and Dietetics (hsv//eng)
Keyword
- Homocysteine
- Obesity
- Dyslipidaemia
- Insulin resistance
- Metabolic syndrome
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database